NASDAQ · Drug Manufacturers - Specialty & Generic

Harrow, Inc. (HROW) Stock

$30.52 -0.33% NASDAQ: HROW Healthcare

Valuation

MetricValue
Price$30.52
Market Cap$1.14B
P/E Ratio-30.94
P/B Ratio75.46
P/S Ratio4.15
EPS (TTM)$2.72
52-Week High$54.85
52-Week Low$28.54
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-103.86%
ROA-8.93%
ROCE1.81%
Gross Margin74.11%
Operating Margin10.47%
Net Margin-13.51%
Debt/Equity19.79
Current Ratio2.21

Annual Financials (USD)

Metric20212022202320242025
Revenue$72.0M$89.0M$130.0M$200.0M$272.0M
Operating Profit$2.0M$2.0M$0$9.0M$39.0M
Net Profit$-18.0M$-14.0M$-24.0M$-17.0M$-5.0M
EPS$-0.69$-0.51$-0.75$-0.49$-0.14
Op Margin2.2%2.2%0.3%4.4%14.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$98.0M$157.0M$312.0M$389.0M$399.0M
Total Liabilities$87.0M$130.0M$242.0M$320.0M$347.0M
Cash$42.0M$96.0M$74.0M$47.0M$73.0M
Borrowings$78.0M$112.0M$191.0M$229.0M$252.0M

Latest News

Harrow Expands Retina Portfolio With US Launch of Byooviz MT Newswires · Jul 1, 2026 Harrow Announces Commercial Launch of BYOOVIZ® in the United States GlobeNewswire · Jul 1, 2026 Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow Business Wire · Jul 1, 2026 GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1 Insider Monkey · Jun 23, 2026 Is Harrow, Inc. (HROW) A Good Stock To Buy Now? Insider Monkey · Jun 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$5.0M$2.0M$4.0M$-22.0M$44.0M
Investing Cash Flow$-47.0M$-10.0M$-305.0M$-72.0M$-7.0M
Financing Cash Flow$-19.0M$0$-13.0M$-2.0M$-25.0M
Net Cash Flow$38.0M$54.0M$-22.0M$-27.0M$26.0M
Free Cash Flow$-23.0M$-6.0M$-149.0M$-61.0M$43.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA303.72
FCF Yield0.50%
Quick Ratio2.08
Interest Coverage0.25
Return 1Y13.40%
Return 3Y97.08%
Return 5Y407.26%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Harrow, Inc.

Harrow, Inc. is led by CEO Mark L. Baum, employs 382 people, headquartered in US, publicly traded since 2007.

Harrow, Inc. (HROW) stock trades at $30.52 with a market capitalization of $1.14B. The stock is valued at a price-to-earnings (P/E) ratio of -30.94, price-to-book of 75.46, price-to-sales of 4.15. Over the past 52 weeks the stock has ranged between $28.54 and $54.85, and currently trades 44.4% below its 52-week high.

On profitability, Harrow, Inc. generates a return on equity (ROE) of -103.86%, return on capital employed of 1.81%, an operating margin of 10.47%, a net profit margin of -13.51%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides